These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 9746932)
41. Aging-related increased expression of inducible nitric oxide synthase and cytotoxicity markers in rat hypothalamic regions associated with male reproductive function. Ferrini M; Wang C; Swerdloff RS; Sinha Hikim AP; Rajfer J; Gonzalez-Cadavid NF Neuroendocrinology; 2001 Jul; 74(1):1-11. PubMed ID: 11435753 [TBL] [Abstract][Full Text] [Related]
42. The circadian system in Alzheimer's disease: disturbances, mechanisms, and opportunities. Coogan AN; Schutová B; Husung S; Furczyk K; Baune BT; Kropp P; Häßler F; Thome J Biol Psychiatry; 2013 Sep; 74(5):333-9. PubMed ID: 23273723 [TBL] [Abstract][Full Text] [Related]
43. DNA damage distribution in the human brain as shown by in situ end labeling; area-specific differences in aging and Alzheimer disease in the absence of apoptotic morphology. Lucassen PJ; Chung WC; Kamphorst W; Swaab DF J Neuropathol Exp Neurol; 1997 Aug; 56(8):887-900. PubMed ID: 9258259 [TBL] [Abstract][Full Text] [Related]
44. Increased metabolic activity in nucleus basalis of Meynert neurons in elderly individuals with mild cognitive impairment as indicated by the size of the Golgi apparatus. Dubelaar EJ; Mufson EJ; ter Meulen WG; Van Heerikhuize JJ; Verwer RW; Swaab DF J Neuropathol Exp Neurol; 2006 Mar; 65(3):257-66. PubMed ID: 16651887 [TBL] [Abstract][Full Text] [Related]
45. Bright light therapy: improved sensitivity to its effects on rest-activity rhythms in Alzheimer patients by application of nonparametric methods. Van Someren EJ; Swaab DF; Colenda CC; Cohen W; McCall WV; Rosenquist PB Chronobiol Int; 1999 Jul; 16(4):505-18. PubMed ID: 10442243 [TBL] [Abstract][Full Text] [Related]
46. The supraoptic and paraventricular nuclei of the human hypothalamus in relation to sex, age and Alzheimer's disease. Goudsmit E; Hofman MA; Fliers E; Swaab DF Neurobiol Aging; 1990; 11(5):529-36. PubMed ID: 2234284 [TBL] [Abstract][Full Text] [Related]
47. Ageing and the diurnal expression of the mRNAs for vasopressin and for the V1a and V1b vasopressin receptors in the suprachiasmatic nucleus of male rats. Kalamatianos T; Kalló I; Coen CW J Neuroendocrinol; 2004 Jun; 16(6):493-501. PubMed ID: 15189323 [TBL] [Abstract][Full Text] [Related]
48. Exposure of pregnant rats to restricted feeding schedule synchronizes the SCN clocks of their fetuses under constant light but not under a light-dark regime. Nováková M; Sládek M; Sumová A J Biol Rhythms; 2010 Oct; 25(5):350-60. PubMed ID: 20876815 [TBL] [Abstract][Full Text] [Related]
49. [A chronobiological approach in treatment of sleep disturbances in Alzheimer's dementia patients]. Doljansky JT; Dagan Y Harefuah; 2006 Jun; 145(6):437-40, 470. PubMed ID: 16838900 [TBL] [Abstract][Full Text] [Related]
50. Single unit activity of the suprachiasmatic nucleus and surrounding neurons during the wake-sleep cycle in mice. Sakai K Neuroscience; 2014 Feb; 260():249-64. PubMed ID: 24355494 [TBL] [Abstract][Full Text] [Related]
51. Changes in vasopressin neurons and fibers in aging and Alzheimer's disease: reversibility in the rat. Goudsmit E; Filers E; Swaab DF Prog Clin Biol Res; 1989; 317():1193-208. PubMed ID: 2690091 [TBL] [Abstract][Full Text] [Related]
52. Hypothalamic vasopressin and oxytocin mRNA expression in relation to depressive state in Alzheimer's disease: a difference with major depressive disorder. Meynen G; Unmehopa UA; Hofman MA; Swaab DF; Hoogendijk WJ J Neuroendocrinol; 2009 Aug; 21(8):722-9. PubMed ID: 19500216 [TBL] [Abstract][Full Text] [Related]
53. Alterations in the circadian rest-activity rhythm in aging and Alzheimer's disease. Witting W; Kwa IH; Eikelenboom P; Mirmiran M; Swaab DF Biol Psychiatry; 1990 Mar; 27(6):563-72. PubMed ID: 2322616 [TBL] [Abstract][Full Text] [Related]
54. Effect of timed bright light treatment for rest-activity disruption in institutionalized patients with Alzheimer's disease. Dowling GA; Mastick J; Hubbard EM; Luxenberg JS; Burr RL Int J Geriatr Psychiatry; 2005 Aug; 20(8):738-43. PubMed ID: 16035127 [TBL] [Abstract][Full Text] [Related]
55. The cholinergic system in aging and neuronal degeneration. Schliebs R; Arendt T Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918 [TBL] [Abstract][Full Text] [Related]
56. Diurnal changes of arginine vasopressin-enhanced green fluorescent protein fusion transgene expression in the rat suprachiasmatic nucleus. Maruyama T; Ohbuchi T; Fujihara H; Shibata M; Mori K; Murphy D; Dayanithi G; Ueta Y Peptides; 2010 Nov; 31(11):2089-93. PubMed ID: 20727931 [TBL] [Abstract][Full Text] [Related]
57. Vasopressin and the output of the hypothalamic biological clock. Kalsbeek A; Fliers E; Hofman MA; Swaab DF; Buijs RM J Neuroendocrinol; 2010 May; 22(5):362-72. PubMed ID: 20088910 [TBL] [Abstract][Full Text] [Related]
58. Estrogen receptors and metabolic activity in the human tuberomamillary nucleus: changes in relation to sex, aging and Alzheimer's disease. Ishunina TA; van Heerikhuize JJ; Ravid R; Swaab DF Brain Res; 2003 Oct; 988(1-2):84-96. PubMed ID: 14519529 [TBL] [Abstract][Full Text] [Related]
59. DNA end joining activity is reduced in Alzheimer's disease. Shackelford DA Neurobiol Aging; 2006 Apr; 27(4):596-605. PubMed ID: 15908050 [TBL] [Abstract][Full Text] [Related]
60. Diurnal and seasonal rhythms of neuronal activity in the suprachiasmatic nucleus of humans. Hofman MA; Swaab DF J Biol Rhythms; 1993; 8(4):283-95. PubMed ID: 8032088 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]